TITLE

Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats

AUTHOR(S)
Yang, Zhikun; Li, Kanghua; Yan, Xi; Dong, Fangtian; Zhao, Chunhua
PUB. DATE
October 2010
SOURCE
Graefe's Archive of Clinical & Experimental Ophthalmology;Oct2010, Vol. 248 Issue 10, p1415
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Diabetic retinopathy is a common complication of diabetes, which is caused by injury to retinal microvasculature and neurons. Mesenchymal stem cells (MSCs), which proved to have multi-linkage differentiation capacity, including endothelial cells and neurons, might be a promising cell therapy resource. The current pilot study was performed using the streptozotocin (STZ) rat model of diabetic retinopathy injected intravenously with human adipose-derived mesenchymal stem cells (AMSCs) in an effort to investigate the potency and possible therapeutic effects of AMSCs. Methods: Four experimental groups of Wistar rats were included in the current study: an untreated control group of STZ diabetic rats ( n = 10), a normal non-diabetic control group ( n = 20), an AMSC therapy group of STZ diabetic rats ( n = 50), and a sham group of STZ diabetic rats ( n = 50). Blood glucose levels were monitored closely. Immunofluorescence was used to study AMSC distribution and differentiation. The integrity of the blood-retinal barrier (BRB) was evaluated by Evans blue dye infusion to evaluate the therapeutic effects. Results: After 1 week of transplantation, a significant reduction in blood glucose levels was observed in the AMSC therapy group relative to the sham group. BRB integrity was also improved, as less Evans blue dye leakage was observed. Donor cells were observed in the retinas of therapy group rats, and they expressed rhodopsin and glial fibrillary acidic protein (GFAP), specific markers for photoreceptors and astrocytes, respectively. Conclusions: Taken together, the results of the current study suggest that AMSCs may improve the integrity of the BRB in diabetic rats by differentiation into photoreceptor and glial-like cells in the retina and by reducing the blood glucose levels. Furthermore, the data presented herein provide evidence that AMSCs may serve as a promising therapeutic approach for diabetic retinopathy.
ACCESSION #
52995819

 

Related Articles

  • Expression of Endoplasmic Reticulum Stress-Related Factors in the Retinas of Diabetic Rats. Shu Yan; Cui Zheng; Zhi-qi Chen; Rong Liu; Gui-gang Li; Wei-kun Hu; Han Pei; Bin Li // Experimental Diabetes Research;2012, Special section p1 

    Recent reports show that ER stress plays an important role in diabetic retinopathy (DR), but ER stress is a complicated process involving a network of signaling pathways and hundreds of factors,What factors involved in DR are not yet understood. We selected 89 ER stress factors from more than...

  • Salutary Effect of Pigment Epithelium-Derived Factor in Diabetic Nephropathy. Wang, Joshua J.; Zhang, Sarah X.; Mott, Robert; Knapp, Ryan R.; Cao, Wei; Lau, Kai; Ma, Jian-xing // Diabetes;Jun2006, Vol. 55 Issue 6, p1678 

    Diabetic nephropathy is a major complication of diabetes and a leading cause of end-stage renal diseases in the U.S. Pigment epithelium-derived factor (PEDF) is a potent angiogenic inhibitor that has been extensively studied in diabetic retinopathy. Recently, we reported that PEDF is expressed...

  • Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes. Navaratna, Deepti; McGuire, Paul G.; Menicucci, Gina; Das, Arup // Diabetes;Sep2007, Vol. 56 Issue 9, p2380 

    OBJECTIVE--Increased vascular permeability due to alteration of the blood-retinal barrier (BRB) is one of the major complications in early diabetes. The aim of the present study was to determine whether diabetes alters the cellular expression and distribution of the adherens junction protein...

  • The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy. Gerhardinger, Chiara; Dagher, Zeina; Sebastian, Paola; Park, Yong Seek; Lorenzi, Mara // Diabetes;Jul2009, Vol. 58 Issue 7, p1659 

    OBJECTIVE--Prevention of diabetic retinopathy would benefit from availability of drugs that preempt the effects of hyperglycemia on retinal vessels. We aimed to identify candidate drug targets by investigating the molecular effects of drugs that prevent retinal capillary demise in the diabetic...

  • Topical Administration of Somatostatin Prevents Retinal Neurodegeneration in Experimental Diabetes. Hernández, Cristina; García-Ramírez, Marta; Corraliza, Lidia; Fernández-Carneado, Jimena; Farrera-Sinfreu, Josep; Ponsati, Berta; González-Rodríguez, Águeda; Valverde, Ángela M.; Simó, Rafael // Diabetes;Jul2013, Vol. 62 Issue 7, p2569 

    Retinal neurodegeneration is an early event in the pathogenesis of diabetic retinopathy (DR). Somatostatin (SST) is an endogenous neuroprotective peptide that is downregulated in the diabetic eye. The aim of the study was to test the usefulness of topical administration of SST in preventing...

  • Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats. Xiupu Shi; Sha Liao; Huijuan Mi; Changrun Guo; Dongli Qi; Fei Li; Chunfeng Zhang; Zhonglin Yang // Molecules;Nov2012, Vol. 17 Issue 11, p12868 

    Diabetic retinopathy is a complex disease that potentially involves increased production of advanced glycosylation end products (AGEs) and elevated aldose reductase (AR) activity, which are related with oxidative stress and inflammation. The aim of this study was to investigate the effects of...

  • TETRACYCLINES INHIBIT PROTEIN GLYCATION IN EXPERIMENTAL DIABETES. RYAN, M. E.; RAMAMURTHY, N. S.; GOLUB, L. M. // Advances in Dental Research;Nov1998, Vol. 12 Issue 1, p152 

    Glycation of proteins, which is accelerated in the diabetic state, has been implicated in many of the long-term complications of diabetes. This process can be inhibited by members of the tetracycline family of compounds. This novel finding is supported by studies conducted on drug...

  • Hypoglycemic and Hypocholesterolemic Effects of Botryosphaeran from Botryosphaeria rhodina MAMB-05 in Diabetes-Induced and Hyperlipidemia Conditions in Rats. Miranda-Nantes, Carolina C. B. O.; Fonseca, Eveline A. I.; Zaia, Cassia T. B. V.; Dekker, Robert F. H.; Khaper, Neelam; Castro, Inar A.; Barbosa, Aneli M. // Mycobiology;Sep2011, Vol. 39 Issue 3, p187 

    Botryosphaeran, a water-soluble exopolysaccharide of the β-(1 → 3;1 → 6)-D-glucan type that has been isolated from the culture medium of Botryosphaeria rhodina MAMB-05 grown in submerged fermentation using glucose as the sole carbon source, was previously demonstrated to be...

  • Targeting Apoptosis in the Heart of Streptozotocin-Induced Diabetic Rats. Baraka, Azza; AbdelGawad, Hala // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2010, Vol. 15 Issue 2, p175 

    The article presents a study on targeting apoptosis in the heart of streptozotocin-induced diabetic rats. The purpose of the study was to address the issue of cardiomyocyte apoptosis as a contributor in the development of diabetic cardiomyopathy. It also aimed to identify whether the apoptosis...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics